LIMITED OFFER
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Immunomodulatory Biomaterials and Nano-immunotherapies reviews the general cellular and biochemical barriers of the tumor microenvironment and other immune diseases, the ways they… Read more
LIMITED OFFER
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Immunomodulatory Biomaterials and Nano-immunotherapies reviews the general cellular and biochemical barriers of the tumor microenvironment and other immune diseases, the ways they are addressed by modern immunotherapies, and the specific barriers facing particular immunotherapeutic approaches. The latest research on immunomodulatory biomaterials is examined, providing a perspective on their future opportunities in modulating disease treatment strategies. Translational considerations and lessons learned from the various components of nanotechnology-enabled immunotherapies, including conventional immunotherapies, nucleic acids, nanotechnology, and biotechnology-based therapeutics are assessed. Finally, a framework for the development of the next generation of nanotechnology-enabled immunotherapies is detailed, providing guidance and suggestions for those interested in the development of novel immunomodulatory nanobiomaterials. Immunomodulatory Biomaterials and Nano-immunotherapies is a key reference for researchers and developers working in biomaterials, nanotechnology, immunology, biomedical engineering and pharmaceutical sciences.
Researchers and postgraduate students in the fields of materials science, nanotechnology, and immunology, Clinical scientists and R&D groups developing novel, biocompatible materials for disease treatment.
TW
SZ
Dr. Steven Zanganeh is an Assistant Professor at the New York Institute of Technology, USA. He earned his PhD in Biomedical Engineering from the University of Connecticut, USA, in 2014. He completed his postdoctoral training at Stanford University, USA, and Memorial Sloan Kettering Cancer Center in New York, USA.